Clinical Laserthermia Financials
| CLS-B Stock | SEK 4.36 0.14 3.11% |
Clinical |
Understanding current and past Clinical Laserthermia Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Clinical Laserthermia's financial statements are interrelated, with each one affecting the others. For example, an increase in Clinical Laserthermia's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Clinical Laserthermia's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Clinical Laserthermia Systems. Check Clinical Laserthermia's Beneish M Score to see the likelihood of Clinical Laserthermia's management manipulating its earnings.
Clinical Laserthermia Stock Summary
Clinical Laserthermia competes with Xvivo Perfusion, SpectraCure, and Senzime AB. Clinical Laserthermia Systems AB develops and markets therapies, systems, and single-use instruments for thermal treatment of solid cancer tumors in Sweden. Clinical Laserthermia Systems AB has a collaboration agreement with Image Guided Therapy SA to develop and commercialize a software product for MR-generated temperature monitoring and a collaborative license and co-development agreement with MRI Interventions, Inc. to provide navigation and laser ablation platforms for use in spine and neurosurgery. Clinical Laserthermia is traded on Stockholm Stock Exchange in Sweden.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0002756130 |
| Business Address | Building 405, Lund, |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | www.clinicallaser.se |
| Phone | 46 46 15 21 00 |
| Currency | SEK - Swedish Kronor |
You should never invest in Clinical Laserthermia without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Clinical Stock, because this is throwing your money away. Analyzing the key information contained in Clinical Laserthermia's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Clinical Laserthermia Key Financial Ratios
There are many critical financial ratios that Clinical Laserthermia's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Clinical Laserthermia reports annually and quarterly.Clinical Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Clinical Laserthermia's current stock value. Our valuation model uses many indicators to compare Clinical Laserthermia value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Clinical Laserthermia competition to find correlations between indicators driving Clinical Laserthermia's intrinsic value. More Info.Clinical Laserthermia Systems is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Clinical Laserthermia's earnings, one of the primary drivers of an investment's value.Clinical Laserthermia Systematic Risk
Clinical Laserthermia's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Clinical Laserthermia volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Clinical Laserthermia correlated with the market. If Beta is less than 0 Clinical Laserthermia generally moves in the opposite direction as compared to the market. If Clinical Laserthermia Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Clinical Laserthermia is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Clinical Laserthermia is generally in the same direction as the market. If Beta > 1 Clinical Laserthermia moves generally in the same direction as, but more than the movement of the benchmark.
Clinical Laserthermia November 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Clinical Laserthermia help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Clinical Laserthermia Systems. We use our internally-developed statistical techniques to arrive at the intrinsic value of Clinical Laserthermia Systems based on widely used predictive technical indicators. In general, we focus on analyzing Clinical Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Clinical Laserthermia's daily price indicators and compare them against related drivers.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 29.83 | |||
| Value At Risk | (6.73) | |||
| Potential Upside | 8.16 |
Additional Tools for Clinical Stock Analysis
When running Clinical Laserthermia's price analysis, check to measure Clinical Laserthermia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clinical Laserthermia is operating at the current time. Most of Clinical Laserthermia's value examination focuses on studying past and present price action to predict the probability of Clinical Laserthermia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clinical Laserthermia's price. Additionally, you may evaluate how the addition of Clinical Laserthermia to your portfolios can decrease your overall portfolio volatility.